Apellis Pharmaceuticals Inc Cash Flow Quality Index
Apellis Pharmaceuticals Inc cash flow quality index. Apellis Pharmaceuticals Inc (APLS) has a Cash Flow Quality Index of -3.27x as of March 2026. Operating cash flow of $-60.97 Million is below net income of $18.66 Million, suggesting accrual-heavy earnings not yet converted to cash. See Apellis Pharmaceuticals Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Apellis Pharmaceuticals Inc (2025–2025)
Cash flow quality index of Apellis Pharmaceuticals Inc from 2025 to 2025. Historical Cash Flow Quality Index for Apellis Pharmaceuticals Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Apellis Pharmaceuticals Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Apellis Pharmaceuticals Inc Cash Flow Quality Index by Year (2025–2025)
Apellis Pharmaceuticals Inc cash flow quality index by year from 2025 to 2025. Year-by-year earnings quality comparison for Apellis Pharmaceuticals Inc. For the full cash flow conversion analysis, see APLS cash flow metrics.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.02x | $45.33 Million | $22.39 Million | — |